TheraRadar
Data updated: Jun 28, 2026

PROTOPAM CHLORIDE (pralidoxime chloride) · Baxter

Other Approved 1964-03-11

PROTOPAM Chloride is an antidote indicated for the treatment of poisoning caused by organophosphate pesticides and chemicals, including nerve agents. It is also utilized to manage overdosage of anticholinesterase medications used in the treatment of myasthenia gravis. The drug is primarily used to address clinical manifestations such as muscle weakness and respiratory depression in affected patients.

How PROTOPAM CHLORIDE Works

Pralidoxime chloride is a cholinesterase reactivator. It works by displacing the phosphate group from the active site of the acetylcholinesterase enzyme that has been inhibited by an organophosphate pesticide or nerve agent. This restores the enzyme's ability to hydrolyze acetylcholine, thereby reversing the neuromuscular blockade and cholinergic crisis. The drug is most effective when administered before the enzyme-inhibitor complex undergoes "aging," a chemical process that renders the enzyme-inhibitor bond permanent.

3
Indications
--
Phase 3 Trials
2
Priority Reviews
62
Years on Market

Details

Status
Prescription
First Approved
1964-03-11
Routes
INJECTION, ORAL
Dosage Forms
INJECTABLE, TABLET

Companies

Active Ingredient: PRALIDOXIME CHLORIDE

PROTOPAM CHLORIDE Approval History

1965
1966
1967
1968
1969
1970
1971
1972
1973
1974
1975
1976
1977
1978
1979
1980
1981
1982
1983
1984
1985
1986
1987
1988
1989
1990
1991
1992
1993
1994
1995
1996
1997
1998
1999
2000
2001
2002
2003
2004
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Original
New Indication
New Form
Label Update
37 FDA actions from 1964 to 2014
Jan 2014 SUPPL Priority
Mfg · Manufacturing (CMC)
May 2013 SUPPL Priority
Mfg · Manufacturing (CMC)
Nov 2012 SUPPL Priority
Mfg · Manufacturing (CMC)

What PROTOPAM CHLORIDE Treats

3 indications

PROTOPAM CHLORIDE is approved for 3 conditions since its original approval in 1964. These indications span multiple therapeutic areas including oncology, immunology, and more.

  • Organophosphate Poisoning
  • Anticholinesterase Overdose
  • Myasthenia Gravis
Source: FDA Label

PROTOPAM CHLORIDE Competitive Set

Pro

Three rings of competition based on shared molecular targets and treated indications.

Unlock 8 more competitors across all three rings.
Upgrade to Pro

Filters applied: drops same-active-ingredient (505(b)(2) reformulations), route-mismatch (topical vs systemic), and cross-therapeutic-area matches in same-indication rings.

Drugs Similar to PROTOPAM CHLORIDE

3 of 5

FDA-approved drugs for similar conditions. Compare mechanisms and indications to understand treatment alternatives.

IMAAVY
NIPOCALIMAB-AAHU
1 shared
Johnson & Johnson
Shared indications:
Myasthenia Gravis
MESTINON
PYRIDOSTIGMINE BROMIDE
1 shared
BAUSCH
Shared indications:
Myasthenia Gravis
RYSTIGGO
ROZANOLIXIZUMAB-NOLI
1 shared
UCB INC
Shared indications:
Myasthenia Gravis
🔬

Active Pipeline

Pro

Ongoing clinical trials by development phase

Loading...

Key Completed Trials

Pro

Completed studies with published results, ranked by significance

Loading...
📊

Trial Timeline

Full development history with FDA approval milestones

|
Loading...
Understanding FDA Approval Types
Count Type What it means
- ORIG Original approval - drug first enters market
- SUPPL - Efficacy New indication (new disease/condition approved)
- SUPPL - Labeling Label text changes (warnings, dosing updates)
- SUPPL - Manufacturing Production changes (new facility)
- SUPPL - Chemistry Formulation changes (new dosage strength)

Green lines in the timeline show ORIG and Efficacy approvals - the clinically meaningful milestones.

PROTOPAM CHLORIDE FDA Label Details

Indications & Usage

FDA Label (PDF)

PROTOPAM Chloride is indicated as an antidote: 1. In the treatment of poisoning due to those pesticides and chemicals (e.g., nerve agents) of the organophosphate class which have anticholinesterase activity and 2. In the control of overdosage by anticholinesterase drugs used in the treatment of myasthenia gravis. The principal indications for the use of PROTOPAM Chloride are muscle weakness and respiratory depression. In severe poisoning, respiratory depression may be due to muscle weakness.

Track PROTOPAM CHLORIDE with TheraRadar Pro

Watchlist alerts, full database access, CSV exports across 14,000+ drugs.

Upgrade to Pro

Data Sources

Data sourced from official FDA and NIH databases. Click links to verify on original sources.